Full_Cells_layout-Vertical_PMS186

First Page		Document Content
Date: 2012-11-21 08:51:34 Anatomy Haemophilia Coagulation Factor VII Partial thromboplastin time Desmopressin Bleeding Factor IX Idiopathic thrombocytopenic purpura Blood Coagulation system Medicine		Full_Cells_layout-Vertical_PMS186 Add to Reading List Source URL: www1.wfh.org Download Document from Source Website File Size: 255,89 KB Share Document on Facebook

	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1q38M - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1pMmB - View Document
	13307 FT Factor VII plasma deficient DocID: 1mVEV - View Document
	UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A • DocID: 1kAcN - View Document

	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1q38M - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1pMmB - View Document
	13307 FT Factor VII plasma deficient DocID: 1mVEV - View Document
	UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A • DocID: 1kAcN - View Document